Categoria: Articoli in lingua originale

Men with type 2 diabetes have an increased risk for major cardiovascular events in the 3 months following a severe hypoglycemia episode, according to findings of a post hoc analysis of data from the Veterans Affairs Diabetes Trial. In addition, researchers found that intensive glucose-lowering therapy can raise the risk

Scientists believe that the diabetes type LADA may actually be a hybrid of type 1 diabetes and type 2 diabetes. LADA is short for Latent Autoimmune Diabetes of Adulthood. It is commonly misdiagnosed as type 2 diabetes because type 2 is mostly diagnosed in adulthood. Unlike with type 1 diabetes, people diagnosed

The sodium-glucose cotransporter type 2 (SGLT2) inhibitor empagliflozin (Jardiance, Boehringer Ingelheim/Eli Lilly) improved glycemic control and weight in type 1 diabetes, but also increased the risk for diabetic ketoacidosis (DKA), new data show. Findings from the Empagliflozin as Adjunctive to Insulin Therapy (EASE) program were presented October 4 here at

It’s not always easy — even for doctors — to tell if someone has type 1 or type 2 diabetes when they’re diagnosed as an adult. And a new study finds mistakes are common. That’s what happened to British Prime Minister Theresa May when she was diagnosed with type 2

Achieving good early control of type 2 diabetes is associated with a 20% reduction in risk of complications over a 10-year period, according to a new study. The study shows how getting diabetes under control early can have very beneficial, lasting effects. More good news is that many people with type 2

The old antihypertensive drug verapamil may help reduce insulin requirements and hypoglycemic episodes in adults with type 1 diabetes, new research suggests. Results from the study were published online July 9 as a research letter in Nature Medicine by Anath Shalev, MD, professor of medicine and director of the University of Alabama

The FreeStyle Libre lowers health costs and improves treatment adherence compared with self-monitoring of blood glucose levels (SMBG), a US study shows. The Libre and continuous glucose monitors devices measure glucose levels throughout the day, but people are still advised to perform standard blood glucose tests to confirm accuracy, particularly before making any treatment

By Kristin J. Kelley Edited by André Sofair, MD, MPH The FDA has approved a continuous glucose monitoring (CGM) system with a fully implantable glucose sensor that can be worn for up to 90 days, as opposed to 7 days like many other sensors. The Eversense CGM system, approved for adults

By Amy Orciari Herman Edited by André Sofair, MD, MPH Children born to mothers with type 1 diabetes face increased risk for autism spectrum disorder, according to findings reported in JAMA. Previous research suggested an association with type 2 diabetes and gestational diabetes. Researchers retrospectively studied the records of nearly 420,000 children

By Joe Elia Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Measuring glycated hemoglobin and fasting glucose from the same blood sample can confirm diabetes, a study in the Annals of Internal Medicine suggests. Researchers followed roughly 1000 patients who had elevated measures of glycated hemoglobin or fasting glucose